Veru Inc Stock Analysis
| VERU Stock | USD 2.95 0.06 1.99% |
Veru Inc is undervalued with Real Value of 7.16 and Hype Value of 3.21. The main objective of Veru stock analysis is to determine its intrinsic value, which is an estimate of what Veru Inc is worth, separate from its market price. There are two main types of Veru's stock analysis: fundamental analysis and technical analysis.
The Veru stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Veru is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Veru Stock trading window is adjusted to America/New York timezone.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veru Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. Veru Stock Analysis Notes
About 14.0% of the company outstanding shares are owned by insiders. The book value of Veru was at this time reported as 1.05. The company has Price/Earnings (P/E) ratio of 240.0. Veru Inc recorded earning per share (EPS) of 6.0. The entity last dividend was issued on the 28th of April 2014. The firm had 1:10 split on the 11th of August 2025. Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. Veru operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 252 people. For more information please call the company at 305 509 6897 or visit https://verupharma.com.Veru Inc Investment Alerts
| Veru Inc generated a negative expected return over the last 90 days | |
| Veru Inc has high historical volatility and very poor performance | |
| Veru Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 16.89 M. Net Loss for the year was (37.8 M) with profit before overhead, payroll, taxes, and interest of 5.85 M. | |
| Veru Inc currently holds about 100.55 M in cash with (21.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
| Veru Inc has a poor financial position based on the latest SEC disclosures | |
| Roughly 14.0% of the company outstanding shares are owned by insiders |
Veru Inc Upcoming and Recent Events
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Veru Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 44.1 M.Veru Profitablity
The company has Profit Margin (PM) of (1.94) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.27) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.27.Technical Drivers
As of the 31st of October, Veru has the Variance of 31.07, risk adjusted performance of (0.06), and Coefficient Of Variation of (929.25). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Veru Inc, as well as the relationship between them.Veru Inc Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Moving Average is predictive technique used to analyze Veru Inc price data points by creating a series of averages of different subsets of Veru entire price series.
Veru Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Veru insiders, such as employees or executives, is commonly permitted as long as it does not rely on Veru's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Veru insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Veru Outstanding Bonds
Veru issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Veru Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Veru bonds can be classified according to their maturity, which is the date when Veru Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| VERTICAL U S Corp BondUS92537RAA77 | View | |
| US92535UAB08 Corp BondUS92535UAB08 | View |
Veru Predictive Daily Indicators
Veru intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Veru stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 8352.9 | |||
| Daily Balance Of Power | (0.43) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 2.92 | |||
| Day Typical Price | 2.93 | |||
| Period Momentum Indicator | (0.06) | |||
| Relative Strength Index | 54.84 |
Veru Forecast Models
Veru's time-series forecasting models are one of many Veru's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Veru's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Veru Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Veru prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Veru shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Veru. By using and applying Veru Stock analysis, traders can create a robust methodology for identifying Veru entry and exit points for their positions.
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. Veru operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 252 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Veru to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Additional Tools for Veru Stock Analysis
When running Veru's price analysis, check to measure Veru's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veru is operating at the current time. Most of Veru's value examination focuses on studying past and present price action to predict the probability of Veru's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veru's price. Additionally, you may evaluate how the addition of Veru to your portfolios can decrease your overall portfolio volatility.